PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2008
CASE
AUTH/2087/1/08 Flynn Pharma ⭐ Case of the Week

AUTH/2087/1/08: UCB v Flynn Pharma β€” β€œDear Doctor” letter during Equasym shortage and β€˜only direct replacement’ claim for Medikinet XL

Flynn sent a β€œDear Doctor” letter during an Equasym supply shortage, promoting Medikinet/Medikinet XL. Panel found no issue with referencing the shortage,…

2015
CASE
Daiichi-Sankyo UK

Daiichi-Sankyo photo booth at ESC Congress: emailed delegate photos ruled a prohibited gift (Clause 18.1)

At ESC 2015, Daiichi-Sankyo emailed delegates photos taken in a stand photo booth. PMCPA ruled the emailed photos were a gift supplied…

2016
CASE
AUTH/2855/7/16 Boehringer Ingelheim

Boehringer Ingelheim and Lilly: Abasaglar email wrongly claimed formulary approval in NHS Sunderland CCG (AUTH/2855/7/16, AUTH/2856/7/16)

A promotional email said Abasaglar was approved on the NHS Sunderland CCG formulary. The Panel found this misleading because no such formulary…

2016
CASE
AUTH/2924/12/16 Lincoln Medical

Lincoln Medical website: β€˜About us’ page held to advertise POMs to the public (AUTH/2924/12/16)

A pharmacist complained that Lincoln Medical’s website listed POM brand names and indications without access controls. The Panel ruled this amounted to…

2016
CASE
AUTH/2868/8/16 Sanofi

AUTH/2868/8/16: Janssen-Cilag v Sanofi Genzyme β€” EULAR stand held to indirectly promote unlicensed sarilumab (IL‑6 focus)

At EULAR 2016, an IL‑6 disease-awareness stand (plus linked symposium/posters) was ruled to have prepared the market for unlicensed sarilumab. Breaches of…

2017
CASE
AUTH/2925/1/17 Pfizer ⭐ Case of the Week

Pfizer websites: out-of-date prescribing information on Vfend leavepiece and Depo‑Provera PI (AUTH/2925/1/17)

A health professional alleged multiple Pfizer website items had out-of-date prescribing information. Breaches were found for Vfend and Depo‑Provera (Clause 4.1) and…

2017
CASE
AUTH/2945/3/17 GlaxoSmithKline

AUTH/2945/3/17: Community Pharmacist v GlaxoSmithKline (COPD pharmacist booklet) – No breach

Complaint about an NPA COPD booklet co-branded with GSK, alleging misleading/bias and implied off-label COPD use via β€œEvohaler”. Panel found the device…

2017
CASE
AUTH/2955/4/17 Boehringer Ingelheim

AUTH/2955/4/17: Anonymous employee complaint about call/contact rates at Boehringer Ingelheim (No breach)

Anonymous employee alleged reps were pressured to hit call-rate targets and managed out, risking overcalling. Panel found the allegation unproven and largely…

2017
CASE
AUTH/2972/8/17 UCB Pharma

UCB website governance failures: inaccurate UK product list, lapsed recertification of public materials, and incorrect black triangle display (AUTH/2972/8/17)

UCB’s UK website listed products not in its UK portfolio, hosted public educational materials not recertified within 2 years, and displayed an…

2018
CASE
AUTH/3039/5/18 Dr Falk Pharma

AUTH/3039/5/18: Tillotts v Dr Falk β€” Budenofalk ad misleading due to unclear formulation (Clauses 7.2, 9.1)

A Budenofalk ad listed three indications without clearly identifying the specific formulation, implying all Budenofalk presentations shared those indications. PMCPA ruled the…

2007
CASE
AUTH/2010/6/07 Sanofi ⭐ Case of the Week

AUTH/2010/6/07: GP v Sanofi-Aventis β€” Acomplia claim on cardiometabolic risk factors (No breach)

A GP challenged an Acomplia claim that ~50% of improvements in cardiometabolic risk factors were beyond weight loss. Panel found the claim…

Janssen

Janssen-Cilag: Risperdal Consta ad implied use in under-18s via imagery and β€œPrescribe early” strapline

A Risperdal Consta journal ad showing a lone female in a playground with a doll and the line β€œPrescribe early” was ruled…

2006
CASE
AUTH/1897/10/06 Janssen

Anonymous v Janssen-Cilag (AUTH/1897/10/06): Dubai meeting hospitality complaint – no breach

Anonymous alleged inappropriate hospitality linked to a Dubai South Asian Forum meeting. Janssen-Cilag funded 14 doctors via educational grants (travel, hotel, registration).…

2007
CASE
AUTH/1974/3/07 Merck Sharp & Dohme

AUTH/1974/3/07: Employees v Merck Sharp & Dohme – DEXA service allegations (no breach) and call-rate objectives (breach of Clause 15.9)

Anonymous employees alleged MSD misled the PMCPA about a DEXA placement initiative and raised concerns about rep call-rate targets. No breach for…

2007
CASE
AUTH/1961/2/07 Serono

AUTH/1961/2/07: Anonymous consultant gynaecologist v Serono (international meeting sponsorship) – No breach

Complaint alleged Serono’s international conference invitations were a non-transparent inducement to prescribe. Panel found no evidence of inappropriate hospitality or delegate selection;…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training